Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Expert Opinion on Drug Delivery
|
June 20, 2020
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers
Veronica Chierici, Luca Cavalieri, Alessio Piraino, et al.
Pharmaceutics
|
June 26, 2026
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases
Davide D'Angelo, Stefania Glieca, Lisa Flammini, et al.
Drug Development and Industrial Pharmacy
|
August 8, 2019
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction
Jana Kozáková, Ayça Altay, Vladimír Ždímal, et al.
Pharmaceutics
|
November 27, 2021
Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer
Luciano A Stecanella, Antonio P R Bitencourt, Gustavo Richter Vaz, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 27, 2025
Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms
Eride Quarta, Fabio Sonvico, Ignazio La Mantia, et al.
International Journal of Pharmaceutics
|
December 19, 2022
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs
Davide D'Angelo, Veronica Chierici, Eride Quarta, et al.
Molecules (Basel, Switzerland)
|
November 13, 2021
Design and Characterization of Maltoheptaose-<i>b</i>-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
Marcos Antonio Villetti, Adryana Rocha Clementino, Ilaria Dotti, et al.
Drug Delivery and Translational Research
|
July 15, 2025
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways
Sabrina Banella, Eride Quarta, Martina Brandolini, et al.
Pharmaceutics
|
April 27, 2024
Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis
María S Magi, Yanina de Lafuente, Eride Quarta, et al.
Antibiotics (Basel, Switzerland)
|
February 26, 2025
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections
Yanina de Lafuente, Eride Quarta, María S Magi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Expert Opinion on Drug Delivery
|
June 20, 2020
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers
Veronica Chierici, Luca Cavalieri, Alessio Piraino, et al.
Pharmaceutics
|
June 26, 2026
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases
Davide D'Angelo, Stefania Glieca, Lisa Flammini, et al.
Drug Development and Industrial Pharmacy
|
August 8, 2019
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction
Jana Kozáková, Ayça Altay, Vladimír Ždímal, et al.
Pharmaceutics
|
November 27, 2021
Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer
Luciano A Stecanella, Antonio P R Bitencourt, Gustavo Richter Vaz, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 27, 2025
Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms
Eride Quarta, Fabio Sonvico, Ignazio La Mantia, et al.
International Journal of Pharmaceutics
|
December 19, 2022
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs
Davide D'Angelo, Veronica Chierici, Eride Quarta, et al.
Molecules (Basel, Switzerland)
|
November 13, 2021
Design and Characterization of Maltoheptaose-<i>b</i>-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
Marcos Antonio Villetti, Adryana Rocha Clementino, Ilaria Dotti, et al.
Drug Delivery and Translational Research
|
July 15, 2025
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways
Sabrina Banella, Eride Quarta, Martina Brandolini, et al.
Pharmaceutics
|
April 27, 2024
Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis
María S Magi, Yanina de Lafuente, Eride Quarta, et al.
Antibiotics (Basel, Switzerland)
|
February 26, 2025
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections
Yanina de Lafuente, Eride Quarta, María S Magi, et al.
Page
of 3